A detailed history of Invesco Ltd. transactions in Kempharm, Inc stock. As of the latest transaction made, Invesco Ltd. holds 15,377 shares of KMPH stock, worth $75,962. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,377
Previous 15,632 1.63%
Holding current value
$75,962
Previous $77,000 2.6%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
N/A
-255 Reduced 1.63%
15,377 $75,000
Q2 2024

Aug 13, 2024

SELL
N/A
-287 Reduced 1.8%
15,632 $77,000
Q1 2024

May 14, 2024

SELL
N/A
-585 Reduced 3.54%
15,919 $78,000
Q4 2023

Feb 12, 2024

BUY
N/A
3,133 Added 23.43%
16,504 $81,000
Q2 2023

Aug 11, 2023

BUY
$4.94 - $6.29 $66,052 - $84,103
13,371 New
13,371 $66,000
Q2 2022

Aug 15, 2022

SELL
$4.02 - $5.21 $41,036 - $53,183
-10,208 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.0 - $9.26 $51,040 - $94,526
10,208 New
10,208 $51,000
Q4 2021

Feb 14, 2022

SELL
$7.6 - $10.26 $111,294 - $150,247
-14,644 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$8.72 - $13.31 $28,898 - $44,109
3,314 Added 29.25%
14,644 $136,000
Q2 2021

Aug 17, 2021

BUY
$8.52 - $15.47 $96,531 - $175,275
11,330 New
11,330 $145,000

Others Institutions Holding KMPH

About KEMPHARM, INC


  • Ticker KMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,493,600
  • Market Cap $170M
  • Description
  • KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...
More about KMPH
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.